Cas:220513-46-2 6-Bromo-8-fluoroquinoline manufacturer & supplier

We serve Chemical Name:6-Bromo-8-fluoroquinoline CAS:220513-46-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-Bromo-8-fluoroquinoline

Chemical Name:6-Bromo-8-fluoroquinoline
CAS.NO:220513-46-2
Synonyms:QC-7987;6-Bromo-8-fluoro-1-azanaphthalene;8-fluoro-6-bromoquinoline
Molecular Formula:C9H5BrFN
Molecular Weight:226.04500
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.89000
Exact Mass:224.95900
LogP:3.13640

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like QC-7987 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-fluoro-6-bromoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,QC-7987 Use and application,QC-7987 technical grade,usp/ep/jp grade.


Related News: No administration fees are withdrawn from the fund. This is our gift to our community. The amount of donors and support has been a true blessing, our Surfside webpage lists all the incredible supporters that have help this cause. says President and Founder, Global Empowerment Mission, (GEM), Michael Capponi
Our partners have been so gracious and attentive to the needs of those affected, and we are humbled by the support that continues to pour in. Now, with the support of funding partners EZS 1-(2,3-dihydrobenzofuran-5-yl)-3-(4-(3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)urea manufacturers Now, with the support that continues to pour in, GEM is thrilled to launch our phase 3 program for long term housing with funding partners The Schul of Bal Harbour, EZS Events, Hatzalah of South Florida, and Ygrene. rac-3,4-dihydro-7-hydroxy-2H-1-benzopyran-2-pentanoic acid ethyl ester suppliers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. (Z)-9-methyl-7-(4-oxopentylidene)-2,3,6,7,8,9-hexahydro-4H-quinolizin-4-one vendor & factory.